Data as of Dec 04
| +0.54 / +2.33%|
The 10 analysts offering 12-month price forecasts for Impax Laboratories Inc have a median target of 23.00, with a high estimate of 30.00 and a low estimate of 15.00. The median estimate represents a -3.04% decrease from the last price of 23.72.
The current consensus among 11 polled investment analysts is to Hold stock in Impax Laboratories Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.